Table 2.
Baseline characteristics | Number of patients (%) (n = 548) |
---|---|
Age a | 61 ± 11 a |
Gender | |
Male | 430 (78.5%) |
Female | 118 (21.5%) |
Hypertension | 397 (72.5%) |
Diabetes Mellitus | 177 (32.3%) |
Smoking history | |
Current | 75 (13.7%) |
Former | 306 (55.8%) |
Never | 167 (30.5%) |
Impaired renal function | |
Serum creatinine ≥ 2.0 mg/dl | 4 (0.7%) |
Location of myocardial infarction on CMR | |
Anterior | 263 (48%) |
Lateral | 96 (17.5%) |
Inferior | 170 (31.0%) |
None | 19 (3.5%) |
Medication | |
ACE Inhibitors or Angiotensin II receptor blockers | 455 (83%) |
ACE Inhibitors/Angiotensin II receptor blockers/Aldosterone inhibitors | 461 (84.1%) |
Antiplatelets (clopidogrel, orasugrel, ticagrelor) | 38 (6.9%) |
β‐blockers | 502 (91.6%) |
Diuretics | 227 (41.4%) |
Statins | 499 (91.1%) |
Values are mean ± SD.